Preservation of endocrine function after Ommaya reservoir insertion in children with cystic craniopharyngioma
- PMID: 35925530
- DOI: 10.1007/s11060-022-04099-0
Preservation of endocrine function after Ommaya reservoir insertion in children with cystic craniopharyngioma
Abstract
Introduction: Children with craniopharyngiomas (CP) can experience significant morbidities caused by extensive surgery and/or radiation. Ommaya reservoir insertion (ORI) into cystic CP represents a minimally invasive approach allowing immediate decompression and aims to avoid additional injuries. The purpose of this study was to determine the surgical outcome and relevance of upfront ORI (± intracystic treatment) for preservation of endocrine function.
Methods: We performed a retrospective chart review of children with CP treated at the Hospital for Sick Children between 01/01/2000 and 15/01/2020. Endocrine function was reviewed at the time of initial surgery and throughout follow-up. New endocrinological deficits related to the index procedure were defined as immediate failure (IF), whereas postoperative duration of endocrinological stability (ES) was analyzed using the Kaplan-Meier method. The rate of IF and ES was compared between the treatment groups.
Results: Seventy-nine patients were included and had a median age of 8.3 years (range 2.1-18.0 years); 31 were males. Fifty-three patients with upfront surgical treatment, including 29 ORI and 24 gross total or partial resections had sufficient endocrinological follow-up data. Endocrine dysfunction occurring immediately after the index procedure (IF) was observed in 15 patients (62.5%) in the resection group compared to two patients (6.8%) in the ORI group, odds ratio: 0.05 (CI: 0.01-0.26, p < 0.0001). Excluding those with immediate endocrinological deficits, mean ES after ORI was 19.4 months (CI: 11.6-34.2), compared to 13.4 months (CI:10.6-NA) after surgical resection.
Conclusions: Endocrine function was preserved in patients with upfront ORI (± intracystic treatment), which was confirmed as a minimally invasive procedure with an overall low morbidity profile.
Keywords: Craniopharyngioma; Cystic; Endocrine function; Ommaya reservoir; Resection.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Supraorbital minicraniotomy for open Ommaya reservoir placement in pediatric craniopharyngiomas: a case series and technical report.J Neurosurg Pediatr. 2023 Jun 30;32(4):421-427. doi: 10.3171/2023.5.PEDS2390. Print 2023 Oct 1. J Neurosurg Pediatr. 2023. PMID: 37410604 Review.
-
A reformed surgical treatment modality for children with giant cystic craniopharyngioma.Childs Nerv Syst. 2017 Sep;33(9):1491-1500. doi: 10.1007/s00381-017-3473-3. Epub 2017 Jun 7. Childs Nerv Syst. 2017. PMID: 28593552
-
Ommaya Reservoir System for the Treatment of Cystic Craniopharyngiomas: Surgical Results in a Series of 11 Adult Patients and Review of the Literature.World Neurosurg. 2019 Dec;132:e869-e877. doi: 10.1016/j.wneu.2019.07.217. Epub 2019 Aug 7. World Neurosurg. 2019. PMID: 31400528 Review.
-
Neuroendoscopic surgery combined with Ommaya reservoir placement for cystic craniopharyngiomas: 11 years of experience in a single institution.Br J Neurosurg. 2024 Dec;38(6):1312-1318. doi: 10.1080/02688697.2022.2152776. Epub 2022 Dec 5. Br J Neurosurg. 2024. PMID: 36469601
-
Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome.Childs Nerv Syst. 2005 Aug;21(8-9):747-57. doi: 10.1007/s00381-005-1186-5. Epub 2005 Jul 2. Childs Nerv Syst. 2005. PMID: 15995885 Clinical Trial.
Cited by
-
Current clinical trials for craniopharyngiomas: what's on the horizon?J Neurooncol. 2025 Apr;172(2):281-288. doi: 10.1007/s11060-024-04899-6. Epub 2025 Mar 5. J Neurooncol. 2025. PMID: 40042714 Free PMC article. Review.
-
Visual outcomes after treatment of craniopharyngioma in children: A systematic review.Childs Nerv Syst. 2024 Jun;40(6):1641-1659. doi: 10.1007/s00381-024-06328-5. Epub 2024 Feb 28. Childs Nerv Syst. 2024. PMID: 38416204
-
An update on multimodal management of craniopharyngioma in children.Front Oncol. 2023 May 5;13:1149428. doi: 10.3389/fonc.2023.1149428. eCollection 2023. Front Oncol. 2023. PMID: 37213301 Free PMC article.
-
Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma.Front Oncol. 2024 Jul 10;14:1401761. doi: 10.3389/fonc.2024.1401761. eCollection 2024. Front Oncol. 2024. PMID: 39050573 Free PMC article.
-
Differential proteomic profiles of exosomes in pediatric and adult adamantinomatous craniopharyngioma cyst fluid.Mol Biol Rep. 2024 Nov 7;51(1):1126. doi: 10.1007/s11033-024-10073-y. Mol Biol Rep. 2024. PMID: 39505756
References
-
- Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89(4):547–551. https://doi.org/10.3171/jns.1998.89.4.0547 - DOI - PubMed
-
- Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251. https://doi.org/10.1093/neuonc/noab106 - DOI - PubMed - PMC
-
- Bartels U, Laperriere N, Bouffet E, Drake J (2012) Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol 3:39. https://doi.org/10.3389/fendo.2012.00039 - DOI
-
- Puget S (2012) Treatment strategies in childhood craniopharyngioma. Front Endocrinol 3:64. https://doi.org/10.3389/fendo.2012.00064 - DOI
-
- Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT (2004) Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89(1):81–86. https://doi.org/10.1210/jc.2003-030442 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous